文献速递生殖医学

基于一千例嵌合体胚胎移植结局构建临床胚胎排序系统

Using outcome data from one thousand mosaic embryo transfers to formulate an embryo ranking system for clinical use.
PubMed 文献 · Fertil Steril · 2021-03-06

该汇总分析纳入5561枚整倍体囊胚和1000枚嵌合体囊胚的临床移植数据,比较植入率、持续妊娠/活产率和自然流产率。整倍体组结局显著优于嵌合体组,且全染色体嵌合水平<50%者优于≥50%者,受累染色体数目越多结局越差。据此提出基于嵌合特征和胚胎形态的嵌合体胚胎优先级排序方案。

要点

  • 整倍体胚胎植入率57.2%、持续妊娠/活产率52.3%,均显著优于嵌合体胚胎。
  • 全染色体嵌合水平<50%者植入率44.5%、持续妊娠/活产率36.1%,优于≥50%者。
  • 嵌合累及染色体数目越多结局越差,可作为临床排序依据。

核心结论

  • 嵌合体的水平、类型和受累染色体数目与移植结局显著相关,可据此制定循证排序方案。

研究设计与样本

  • 汇总分析,多中心,纳入5561枚整倍体囊胚和1000枚嵌合体囊胚的临床移植数据。

主要发现

  • 整倍体组、全部嵌合体组和仅全染色体嵌合组的植入率分别为57.2%、46.5%和41.8%,持续妊娠/活产率分别为52.3%、37.0%和31.3%。
  • 整倍体组、全部嵌合体组和仅全染色体嵌合组的自然流产率分别为8.6%、20.4%和25%。
  • 全染色体嵌合水平<50%组与≥50%组的植入率分别为44.5%和30.4%,持续妊娠/活产率分别为36.1%和19.3%。
  • 从节段性异常嵌合到累及3条及以上染色体的复杂非整倍体,植入率从51.6%降至30.4%,持续妊娠/活产率从43.1%降至20.8%。

临床怎么用

  • 临床可综合嵌合水平、嵌合类型和胚胎形态对嵌合体胚胎进行优先级排序,优先移植结局更优的亚类。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study how the attributes of mosaicism identified during preimplantation genetic testing for aneuploidy relate to clinical outcomes, in order to formulate a ranking system of mosaic embryos for intrauterine transfer. DESIGN: Compiled analysis. SETTING: Multi-center. PATIENT(S): A total of 5,561 euploid blastocysts and 1,000 mosaic blastocysts used in clinical transfers in patients undergoing fertility treatment. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Implantation (gestational sac), ongoing pregnancy, birth, and spontaneous abortion (miscarriage before 20 weeks of gestation). RESULT(S): The euploid group had significantly more favorable rates of implantation and ongoing pregnancy/birth (OP/B) compared with the combined mosaic group or the mosaic group affecting only whole chromosomes (implantation: 57.2% vs. 46.5% vs. 41.8%; OP/B: 52.3% vs. 37.0% vs. 31.3%), as well as lower likelihood of spontaneous abortion (8.6% vs. 20.4% vs. 25%). Whole-chromosome mosaic embryos with level (percent aneuploid cells) <50% had significantly more favorable outcomes than the ≥50% group (implantation: 44.5% vs. 30.4%; OP/B: 36.1% vs. 19.3%). Mosaic type (nature of the aneuploidy implicated in mosaicism) affected outcomes, with a significant correlation between number of affected chromosomes and unfavorable outcomes. This ranged from mosaicism involving segmental abnormalities to complex aneuploidies affecting three or more chromosomes (implantation: 51.6% vs. 30.4%; OP/B: 43.1% vs. 20.8%). Combining mosaic level, type, and embryo morphology revealed the order of subcategories regarding likelihood of positive outcome. CONCLUSION(S): This compiled analysis revealed traits of mosaicism identified with preimplantation genetic testing for aneuploidy that affected outcomes in a statistically significant manner, enabling the formulation of an evidence-based prioritization scheme for mosaic embryos in the clinic.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Viotti M, Victor AR, Barnes FL, et al. Using outcome data from one thousand mosaic embryo transfers to formulate an embryo ranking system for clinical use. Fertil Steril. 2021. PMID: 33685629. doi:10.1016/j.fertnstert.2020.11.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。